Literature DB >> 25706356

Mutations in PIGL in a patient with Mabry syndrome.

Ikuma Fujiwara1, Yoshiko Murakami, Tetsuya Niihori, Junko Kanno, Akiko Hakoda, Osamu Sakamoto, Nobuhiko Okamoto, Ryo Funayama, Takeshi Nagashima, Keiko Nakayama, Taroh Kinoshita, Shigeo Kure, Yoichi Matsubara, Yoko Aoki.   

Abstract

Mabry syndrome, hyperphosphatasia mental retardation syndrome (HPMRS), is an autosomal recessive disease characterized by increased serum levels of alkaline phosphatase (ALP), severe developmental delay, intellectual disability, and seizures. Recent studies have revealed mutations in PIGV, PIGW, PIGO, PGAP2, and PGAP3 (genes that encode molecules of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway) in patients with HPMRS. We performed whole-exome sequencing of a patient with severe intellectual disability, distinctive facial appearance, fragile nails, and persistent increased serum levels of ALP. The result revealed a compound heterozygote with a 13-bp deletion in exon 1 (c.36_48del) and a two-base deletion in exon 2 (c.254_255del) in phosphatidylinositol glycan anchor, class L (PIGL) that caused frameshifts resulting in premature terminations. The 13-bp deletion was inherited from the father, and the two-base deletion was inherited from the mother. Expressing c.36_48del or c.254_255del cDNA with an HA-tag at the C- or N-terminus in PIGL-deficient CHO cells only partially restored the surface expression of GPI-anchored proteins (GPI-APs). Nonsynonymous changes or frameshift mutations in PIGL have been identified in patients with CHIME syndrome, a rare autosomal recessive disorder characterized by colobomas, congenital heart defects, early onset migratory ichthyosiform dermatosis, intellectual disability, and ear abnormalities. Our patient did not have colobomas, congenital heart defects, or early onset migratory ichthyosiform dermatosis and hence was diagnosed with HPMRS, and not CHIME syndrome. These results suggest that frameshift mutations that result in premature termination in PIGL cause a phenotype that is consistent with HPMRS.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mabry syndrome; genetic testing; glycosylphosphatidylinositol anchor; hyperphosphatasia mental retardation syndrome

Mesh:

Substances:

Year:  2015        PMID: 25706356     DOI: 10.1002/ajmg.a.36987

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  15 in total

1.  Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy.

Authors:  Thi Tuyet Mai Nguyen; Yoshiko Murakami; Kristen M Wigby; Nissan V Baratang; Justine Rousseau; Anik St-Denis; Jill A Rosenfeld; Stephanie C Laniewski; Julie Jones; Alejandro D Iglesias; Marilyn C Jones; Diane Masser-Frye; Angela E Scheuerle; Denise L Perry; Ryan J Taft; Françoise Le Deist; Miles Thompson; Taroh Kinoshita; Philippe M Campeau
Journal:  Am J Hum Genet       Date:  2018-09-27       Impact factor: 11.025

2.  pigk Mutation underlies macho behavior and affects Rohon-Beard cell excitability.

Authors:  V Carmean; M A Yonkers; M B Tellez; J R Willer; G B Willer; R G Gregg; R Geisler; S C Neuhauss; A B Ribera
Journal:  J Neurophysiol       Date:  2015-07-01       Impact factor: 2.714

3.  Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.

Authors:  Periklis Makrythanasis; Mitsuhiro Kato; Maha S Zaki; Hirotomo Saitsu; Kazuyuki Nakamura; Federico A Santoni; Satoko Miyatake; Mitsuko Nakashima; Mahmoud Y Issa; Michel Guipponi; Audrey Letourneau; Clare V Logan; Nicola Roberts; David A Parry; Colin A Johnson; Naomichi Matsumoto; Hanan Hamamy; Eamonn Sheridan; Taroh Kinoshita; Stylianos E Antonarakis; Yoshiko Murakami
Journal:  Am J Hum Genet       Date:  2016-03-17       Impact factor: 11.025

Review 4.  Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling.

Authors:  Taroh Kinoshita; Morihisa Fujita
Journal:  J Lipid Res       Date:  2015-11-12       Impact factor: 5.922

5.  Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation.

Authors:  Susan Realegeno; Andreas S Puschnik; Amrita Kumar; Cynthia Goldsmith; Jillybeth Burgado; Suryaprakash Sambhara; Victoria A Olson; Darin Carroll; Inger Damon; Tetsuya Hirata; Taroh Kinoshita; Jan E Carette; Panayampalli Subbian Satheshkumar
Journal:  J Virol       Date:  2017-05-12       Impact factor: 6.549

6.  Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.

Authors:  Xiao-Ming Wang; Wing Yan Yik; Peilin Zhang; Wange Lu; Ning Huang; Bo Ram Kim; Darryl Shibata; Madison Zitting; Robert H Chow; Ann B Moser; Steven J Steinberg; Joseph G Hacia
Journal:  Stem Cell Res Ther       Date:  2015-08-29       Impact factor: 6.832

7.  Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.

Authors:  Alistair T Pagnamenta; Yoshiko Murakami; John M Taylor; Consuelo Anzilotti; Malcolm F Howard; Venessa Miller; Diana S Johnson; Shereen Tadros; Sahar Mansour; I Karen Temple; Rachel Firth; Elisabeth Rosser; Rachel E Harrison; Bronwen Kerr; Niko Popitsch; Taroh Kinoshita; Jenny C Taylor; Usha Kini
Journal:  Eur J Hum Genet       Date:  2017-03-22       Impact factor: 4.246

8.  Hyperphosphatasia with mental retardation syndrome, expanded phenotype of PIGL related disorders.

Authors:  Ruqaiah Altassan; Stephanie Fox; Chantal Poulin; Daniela Buhas
Journal:  Mol Genet Metab Rep       Date:  2018-02-06

9.  Large deletion in PIGL: a common mutational mechanism in CHIME syndrome?

Authors:  José Rm Ceroni; Guilherme L Yamamoto; Rachel S Honjo; Chong A Kim; Maria R Passos-Bueno; Débora R Bertola
Journal:  Genet Mol Biol       Date:  2018-02-19       Impact factor: 1.771

Review 10.  The Glycosylphosphatidylinositol biosynthesis pathway in human diseases.

Authors:  Tenghui Wu; Fei Yin; Shiqi Guang; Fang He; Li Yang; Jing Peng
Journal:  Orphanet J Rare Dis       Date:  2020-05-28       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.